Abstract |
Topical diphencyprone (DPCP) can be used to treat in transit and cutaneously metastastatic melanoma. To date, 50 patients have received DPCP therapy for at least 1 month at our institution, with complete clearance of cutaneous disease in 46% and partial response in a further 38% of patients. Topical immunotherapy with DPCP is inexpensive and well-tolerated and should be considered in patients with skin metastases unsuitable for or refractory to other forms of therapy.
|
Authors | Diona L Damian, Robyn P M Saw, John F Thompson |
Journal | Journal of surgical oncology
(J Surg Oncol)
Vol. 109
Issue 4
Pg. 308-13
(Mar 2014)
ISSN: 1096-9098 [Electronic] United States |
PMID | 24522938
(Publication Type: Journal Article, Review)
|
Copyright | © 2013 Wiley Periodicals, Inc. |
Chemical References |
- Cyclopropanes
- diphenylcyclopropenone
|
Topics |
- Administration, Topical
- Animals
- Cyclopropanes
(administration & dosage)
- Dermatitis, Contact
(etiology, immunology)
- Humans
- Immunotherapy
(methods)
- Melanoma
(immunology, pathology, therapy)
- Neoplasm Metastasis
- Skin Neoplasms
(immunology, pathology, therapy)
|